A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)
about
A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of V503 Vaccine Given ...... 11 to 15 Year Olds (V503-007)
@en
type
label
A Study of V503 Vaccine Given ...... 11 to 15 Year Olds (V503-007)
@en
prefLabel
A Study of V503 Vaccine Given ...... 11 to 15 Year Olds (V503-007)
@en
P1132
P1476
A Phase III Open-Label Clinica ...... olescents (11 to 15 Year Olds)
@en
P3098
NCT01073293
P580
2010-04-22T00:00:00Z
P582
2011-06-16T00:00:00Z